134 related articles for article (PubMed ID: 9636152)
1. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.
Malek SN; Dordai DI; Reim J; Dintzis H; Desiderio S
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7351-6. PubMed ID: 9636152
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
[TBL] [Abstract][Full Text] [Related]
3. The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation.
Texido G; Su IH; Mecklenbräuker I; Saijo K; Malek SN; Desiderio S; Rajewsky K; Tarakhovsky A
Mol Cell Biol; 2000 Feb; 20(4):1227-33. PubMed ID: 10648608
[TBL] [Abstract][Full Text] [Related]
4. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk.
Tretter T; Ross AE; Dordai DI; Desiderio S
J Exp Med; 2003 Dec; 198(12):1863-73. PubMed ID: 14662906
[TBL] [Abstract][Full Text] [Related]
5. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.
Dymecki SM; Niederhuber JE; Desiderio SV
Science; 1990 Jan; 247(4940):332-6. PubMed ID: 2404338
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
[TBL] [Abstract][Full Text] [Related]
7. A novel BLK-induced tumor model.
Petersen DL; Berthelsen J; Willerslev-Olsen A; Fredholm S; Dabelsteen S; Bonefeld CM; Geisler C; Woetmann A
Tumour Biol; 2017 Jul; 39(7):1010428317714196. PubMed ID: 28670978
[TBL] [Abstract][Full Text] [Related]
8. Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells.
Samuelson EM; Laird RM; Maue AC; Rochford R; Hayes SM
Immunol Cell Biol; 2012 Jul; 90(6):620-9. PubMed ID: 21894171
[TBL] [Abstract][Full Text] [Related]
9. Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development.
Akerblad P; Sigvardsson M
J Immunol; 1999 Nov; 163(10):5453-61. PubMed ID: 10553071
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement.
Wasserman R; Li YS; Hardy RR
J Immunol; 1995 Jul; 155(2):644-51. PubMed ID: 7608542
[TBL] [Abstract][Full Text] [Related]
11. Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes.
Venkataraman C; Muthusamy N; Muthukkumar S; Bondada S
J Immunol; 1998 Apr; 160(7):3322-9. PubMed ID: 9531290
[TBL] [Abstract][Full Text] [Related]
12. Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice.
Samuelson EM; Laird RM; Papillion AM; Tatum AH; Princiotta MF; Hayes SM
PLoS One; 2014; 9(3):e92054. PubMed ID: 24637841
[TBL] [Abstract][Full Text] [Related]
13. Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.
Wu YY; Georg I; Díaz-Barreiro A; Varela N; Lauwerys B; Kumar R; Bagavant H; Castillo-Martín M; El Salem F; Marañón C; Alarcón-Riquelme ME
J Immunol; 2015 Jun; 194(12):5692-702. PubMed ID: 25972485
[TBL] [Abstract][Full Text] [Related]
14. Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk.
Dymecki SM; Zwollo P; Zeller K; Kuhajda FP; Desiderio SV
J Biol Chem; 1992 Mar; 267(7):4815-23. PubMed ID: 1537861
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune disease-associated haplotypes of BLK exhibit lowered thresholds for B cell activation and expansion of Ig class-switched B cells.
Simpfendorfer KR; Armstead BE; Shih A; Li W; Curran M; Manjarrez-Orduño N; Lee AT; Diamond B; Gregersen PK
Arthritis Rheumatol; 2015 Nov; 67(11):2866-76. PubMed ID: 26246128
[TBL] [Abstract][Full Text] [Related]
16. Discovery of selective irreversible inhibitors of B-Lymphoid tyrosine kinase (BLK).
Fu T; Zuo Y; Zhong Z; Chen X; Pan Z
Eur J Med Chem; 2022 Feb; 229():114051. PubMed ID: 34952433
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of Blk and Fyn Src homology 2 domain-binding proteins occurs in response to antigen-receptor ligation in B cells and constitutively in pre-B cells.
Aoki Y; Isselbacher KJ; Cherayil BJ; Pillai S
Proc Natl Acad Sci U S A; 1994 May; 91(10):4204-8. PubMed ID: 7514299
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and chromosomal localization of the human homologue of a B-lymphocyte specific protein tyrosine kinase (blk).
Drebin JA; Hartzell SW; Griffin C; Campbell MJ; Niederhuber JE
Oncogene; 1995 Feb; 10(3):477-86. PubMed ID: 7845672
[TBL] [Abstract][Full Text] [Related]
19. A Blk-p190RhoGAP signaling module downstream of activated Gα13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion.
Bartolomé RA; Díaz-Martínez M; Coló GP; Arellano-Sánchez N; Torres-Ayuso P; Kleinovink JW; Mérida I; Teixidó J
Cell Signal; 2014 Nov; 26(11):2551-61. PubMed ID: 25025568
[TBL] [Abstract][Full Text] [Related]
20. The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development.
Simpfendorfer KR; Olsson LM; Manjarrez Orduño N; Khalili H; Simeone AM; Katz MS; Lee AT; Diamond B; Gregersen PK
Hum Mol Genet; 2012 Sep; 21(17):3918-25. PubMed ID: 22678060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
